Cleared Traditional

K122458 - VERIZON WIRELESS REMOTE HEALTH MANAGEME...

K122458 is an FDA 510(k) clearance for VERIZON WIRELESS REMOTE HEALTH MANAGEME..., manufactured by Cello Partnership D/B/A Verizon Wireless. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 351-day FDA review.

K122458 · Cello Partnership D/B/A Verizon Wireless · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
351d
Days
Class 2
Risk

K122458 is an FDA 510(k) clearance for the VERIZON WIRELESS REMOTE HEALTH MANAGEMENT SYSTEM. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Cello Partnership D/B/A Verizon Wireless (Washington, US). The FDA issued a Cleared decision on July 30, 2013 after a review of 351 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cello Partnership D/B/A Verizon Wireless devices

FDA 510(k) Submission Details - K122458

510(k) Number K122458 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 2012
Decision Date July 30, 2013
Days to Decision 351 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
226d slower than avg
Panel avg: 125d · This submission: 351d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 75
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K122458.
SURVEYOR S4 MOBILE MONITOR
K141020 · Mortara Instrument, Inc. · Dec 2014
S HEALTH
K132148 · Samsung Electronics Co., Ltd. · Dec 2013
INTELLIVUE CL SPO2 POD AND CL NBP POD, PHILIPS INTELLIVUE PATIENT MONITORS MP5, MP5T, MP5SC
K131913 · Philips Medizin Systeme Boeblingen GmbH · Nov 2013
3M LITTMANN TELESTETH ONLINE AUSCULATION SYSTEM
K120704 · 3M Company · May 2012
3M LITTMANN SCOPE-TO SCOPE SOFTWARE SYSTEM
K101834 · 3M Company · Sep 2010
FORA GW 9014 TELEHEALTH GATEWAY/TD-9014 TELEHEALTH GATEWAY
K100427 · Taidoc Technology Corporation · May 2010